跳至主要内容
临床试验/ACTRN12616000501448
ACTRN12616000501448招募中未知

Does Creatine Enhance the Effects of Cognitive Training in Older Adults with Mild Cognitive Impairment?

niversity of Sydney0 个研究点目标入组 50 人开始时间: 2016年4月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
60 Years 至 o limit(—)
性别
All

入选标准

  • 1. Aged 60 years or older;
  • 2. Ability to read, write and communicate in English;
  • 3. Ability to attend two sessions per week for 12 weeks at the training centre;
  • 4. Sufficient physical abilities (motor, eyesight, hearing) to use a computer;
  • 5. Cognitive impairment in memory or other cognitive domain (i.e., 1.5 SD below their
  • expected level of performance based on normative data), measured within the last 6 months;
  • 6. MCI diagnosis: this will be determined by consensus of three independent clinician raters and will follow Winblad’s criteria.

排除标准

  • 1. Bayler-ADL > 3.0
  • 2. MMSE < 24
  • 3. Geriatric Depression Scale > 7
  • 4. Intellectual disability
  • 5. Current diagnosis of:
  • - Dementia,
  • - Major Depressive Episode (within the last 6 months),
  • - Neurological illness (e.g. epilepsy, Parkinson’s Disease),
  • - Non-affective psychiatric illness (e.g. schizophrenia),
  • - Loss of consciousness >30-minutes in the past 12 months,
  • - Diabetes and/or insulin resistance,
  • - Renal impairment (defined by serum creatinine-estimated Glomerular Filtration Rate <60mL/min)
  • - Gastrointestinal disease or food allergies (e.g. coeliac disease, corn starch allergy and/or irritable bowel syndrome).
  • 6. Electroconvulsive Therapy
  • 7. Current/past alcohol or substance dependence (other than nicotine)
  • 8. Use of cholinesterase inhibitors or other cognitive enhancing drugs
  • 9. Current treatment with diuretics, NSAIDS, Probenecid, Cimetidine, aminoglycoside
  • antibiotics and/or lansopraxolem
  • 10. Clinical history of hepatic disease or chronic or acute renal impairment or failure
  • 11. Presence of abnormal Liver Function Test results: abnormality defined on ANY of the
  • following as per local laboratory thresholds: albumin, alanine transaminase ALT,
  • aspartate transaminase AST, alkaline phosphatase ALP, bilirubin, gamma glutamyl
  • transpeptidase GGT).

研究者

相似试验

Does Creatine Enhance the Effects of Cognitive... | 临床试验